SCHEMBL7206347

SCHEMBL7206347

CC(C)c1[c]c(C(C)C)cc(C(=O)Cc2c(C(C)C)cccc2C(C)C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 3/20 0.43
GABRG2 P18507 2/20 0.43
GABRB3 P28472 2/20 0.43
LPAR1 Q92633 2/20 0.40
SOAT2 O75908 1/20 0.37
MYC P01106 1/20 0.37
SOAT1 P35610 1/20 0.37
MAP2K3 P46734 1/20 0.37
LMNA P02545 2/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
GABRB1 P18505 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
FAAH O00519 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
PTGS1 P23219 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7206928 0.85 FABP3 (0.41) GABRA1SOAT2MYCSOAT1MAP2K3
SCHEMBL7212859 0.84 AKR1B1 (0.45) LMNAKMT2ASMN1; SMN2CYP3A4HPGD
SCHEMBL7206357 0.80 GABRA1 (0.39) GABRA1GABRG2GABRB3LPAR1SOAT2
SCHEMBL7206959 0.78 GLRA1 (0.39) SOAT2MYCSOAT1MAP2K3SCN5A
SCHEMBL7206391 0.78 MAPT (0.47) LMNAKMT2ASMN1; SMN2TSHR
SCHEMBL7206911 0.77 HPGD (0.32) HPGD
SCHEMBL7206345 0.77 GABRA1 (0.41) GABRA1GABRG2GABRB3LPAR1SOAT2
SCHEMBL7207814 0.72 NPC1 (0.39) LMNASMN1; SMN2CYP3A4
SCHEMBL7206360 0.72 FABP3 (0.51) GABRA1GABRG2GABRB3LPAR1SOAT2
SCHEMBL7212823 0.71 L3MBTL1 (0.50) KMT2ACYP1A2CYP3A4HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0841913-B1 USE OF SULFAMIC ACID DERIVATIVES, ACYL SULFONAMIDES OR SULFONYL CARBAMATES FOR THE MANUFACTURE OF A MEDICAMENT FOR LOWERING LIPOPROTEIN LEVELS WARNER LAMBERT CO (US) 2003-02-05 EP claimed